252 related articles for article (PubMed ID: 34068442)
21. Combined targeting of high-mobility group box-1 and interleukin-8 to control micrometastasis potential in gastric cancer.
Chung HW; Jang S; Kim H; Lim JB
Int J Cancer; 2015 Oct; 137(7):1598-609. PubMed ID: 25821182
[TBL] [Abstract][Full Text] [Related]
22. The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-κB signaling pathway.
An X; Zhang L; Yao Q; Li L; Wang B; Zhang J; He M; Zhang J
Mol Cell Endocrinol; 2018 Jul; 470():14-25. PubMed ID: 28478303
[TBL] [Abstract][Full Text] [Related]
23. Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells.
Song B; Song WG; Li ZJ; Xu ZF; Wang XW; Wang CX; Liu J
Cell Biochem Funct; 2012 Jan; 30(1):11-7. PubMed ID: 21953494
[TBL] [Abstract][Full Text] [Related]
24. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway.
Zhang J; Shao S; Han D; Xu Y; Jiao D; Wu J; Yang F; Ge Y; Shi S; Li Y; Wen W; Qin W
Int J Oncol; 2018 Aug; 53(2):659-671. PubMed ID: 29845254
[TBL] [Abstract][Full Text] [Related]
25. Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and Cancer Stemness through ERK/NFκB axis in Osteosarcoma.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Int J Biol Sci; 2024; 20(3):880-896. PubMed ID: 38250151
[TBL] [Abstract][Full Text] [Related]
26. High Mobility Group Box 1 (HMGB1) expression in gastric adenocarcinomas.
Suren D; Arda Gokay A; Sayiner A
J BUON; 2018; 23(2):422-427. PubMed ID: 29745087
[TBL] [Abstract][Full Text] [Related]
27. Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration.
Zhang X; Shi H; Yuan X; Jiang P; Qian H; Xu W
Mol Cancer; 2018 Oct; 17(1):146. PubMed ID: 30292233
[TBL] [Abstract][Full Text] [Related]
28. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
29. Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer.
Zhang Z; Wang M; Zhou L; Feng X; Cheng J; Yu Y; Gong Y; Zhu Y; Li C; Tian L; Huang Q
J Exp Clin Cancer Res; 2015 May; 34(1):51. PubMed ID: 25986235
[TBL] [Abstract][Full Text] [Related]
30. HMGB1 Enhances the AGE-Induced Expression of CTGF and TGF-β via RAGE-Dependent Signaling in Renal Tubular Epithelial Cells.
Cheng M; Liu H; Zhang D; Liu Y; Wang C; Liu F; Chen J
Am J Nephrol; 2015; 41(3):257-66. PubMed ID: 25924590
[TBL] [Abstract][Full Text] [Related]
31. MiR-129-5p inhibits proliferation of gastric cancer cells through targeted inhibition on HMGB1 expression.
Feng J; Guo J; Wang JP; Chai BF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3665-3673. PubMed ID: 32329842
[TBL] [Abstract][Full Text] [Related]
32. [Inhibitory effect of silencing of HMGB1 gene expression on the invasive and metastatic abilities of MGC-803 gastric cancer cells].
Li ZJ; Song B; Liu J; Han JJ; Wang CX; Zhu YX; Xu ZF
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):244-8. PubMed ID: 23985250
[TBL] [Abstract][Full Text] [Related]
33. S100A12 inhibits fibroblast migration via the receptor for advanced glycation end products and p38 MAPK signaling.
Tanaka N; Ikari J; Anazawa R; Suzuki M; Katsumata Y; Shimada A; Suzuki E; Matsuura Y; Kawata N; Tada Y; Tatsumi K
In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):656-664. PubMed ID: 31297698
[TBL] [Abstract][Full Text] [Related]
34. Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression.
Angelopoulou E; Piperi C; Adamopoulos C; Papavassiliou AG
J Mol Med (Berl); 2016 Aug; 94(8):867-74. PubMed ID: 27262996
[TBL] [Abstract][Full Text] [Related]
35. RAGE-dependent NF-kB inflammation processes in the capsule of frozen shoulders.
Yano T; Hagiwara Y; Ando A; Kanazawa K; Koide M; Sekiguchi T; Itaya N; Onoki T; Suzuki K; Tsuchiya M; Sogi Y; Yabe Y; Itoi E
J Shoulder Elbow Surg; 2020 Sep; 29(9):1884-1891. PubMed ID: 32279986
[TBL] [Abstract][Full Text] [Related]
36. High-Mobility Group Box 1 (HMGB1) Induces Migration of Endothelial Progenitor Cell via Receptor for Advanced Glycation End-Products (RAGE)-Dependent PI3K/Akt/eNOS Signaling Pathway.
Zhang Y; You B; Liu X; Chen J; Peng Y; Yuan Z
Med Sci Monit; 2019 Aug; 25():6462-6473. PubMed ID: 31461437
[TBL] [Abstract][Full Text] [Related]
37. The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1.
Tao H; Tang T; Wang S; Wang Z; Ma Y; Cai T; Cheng X; Qi S; Zhang Y; Qi Z
Drug Des Devel Ther; 2019; 13():1221-1231. PubMed ID: 31114162
[No Abstract] [Full Text] [Related]
38. Clinical Implication of the Relationship Between High Mobility Group Box-1 and Tumor Differentiation in Hepatocellular Carcinoma.
Ando K; Sakoda M; Ueno S; Hiwatashi K; Iino S; Minami K; Kawasaki Y; Hashiguchi M; Tanoue K; Mataki Y; Kurahara H; Maemura K; Shinchi H; Natsugoe S
Anticancer Res; 2018 Jun; 38(6):3411-3418. PubMed ID: 29848691
[TBL] [Abstract][Full Text] [Related]
39. High Mobility Group Box1 (HMGB1) released from cancer cells induces the expression of pro-inflammatory cytokines in peritoneal fibroblasts.
Abe A; Kuwata T; Yamauchi C; Higuchi Y; Ochiai A
Pathol Int; 2014 Jun; 64(6):267-75. PubMed ID: 24965109
[TBL] [Abstract][Full Text] [Related]
40. AGEs, RAGEs and s-RAGE; friend or foe for cancer.
Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin
Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
